Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Cancer Research Institute
Aug 24, 2023, 18:16 |
Blog
Paolo Tarantino: Retrospective study by Viale et al. on HER2-low breast cancer.
Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on Twitter: ''Just out on…
Aug 23, 2023, 23:49 |
Blog
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on…
Aug 23, 2023, 21:17 |
Blog
Jim Olsen: Having raised $1 million for pediatric brain tumor research, the Seattle Children's Pink Polka Dots junior guild continues to support our work.
Jim Olsen, Principal Investigator at Seattle Children's Research Institute, Professor at Fred Hutchinson Cancer Research…
Aug 23, 2023, 14:39 |
Blog
Freddy Nguyen: Michael King's and Cindy Reinhart-King's research programs have advanced treatment of cancer and other diseases.
Freddy Nguyen, a Research Fellow at the Massachusetts Institute of Technology, recently shared on LinkedIn:…
Aug 23, 2023, 14:38 |
Blog
APPLY TODAY to The Innovative Molecular Analysis Technologies (IMAT) Program - National Cancer Institute
National Cancer Institute shared on Twitter: "APPLY TODAY: The Innovative Molecular Analysis Technologies (IMAT) Program…
Aug 23, 2023, 14:35 |
Blog
Mark A. Davis: I am so proud to be have been a part of Baptist Health Cancer Care for the last two years...
Quoting Mark A. Davis, COO of Miami Cancer Institute and Baptist Health Cancer Care, on…
Aug 22, 2023, 09:55 |
Drugs
Neeraj Agarwal: Breaking news: Glad to report the news from ph3 Contact-2 trial Cabozantinib + atezolizumab significantly improved outcomes in mCRPC prostate cancer.
Neeraj Agarwal stated on Twitter: "Breaking news: Glad to report the news from ph3 Contact-2 trial…
Aug 21, 2023, 16:51 |
Insight
Ishwaria Subbiah: New guidelines on non-pharmacologic options for cancer symptom management.
Ishwaria Subbiah, the Executive Director of Cancer Care Equity and Professional Wellness at Sarah Cannon…
Aug 20, 2023, 17:41 |
Insight
Vivek Subbiah: Pan-KRAS inhibitors have broad therapeutic implications and merit clinical investigation in patients with KRAS-driven cancers.
According to Vivek Subbiah, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute on LinkedIn: "Pan-KRAS…
Aug 18, 2023, 17:20 |
Blog
Don’t miss NCI’s exclusive interview with Dr. Nancy Hopkins - National Cancer Institute
National Cancer Institute shared on their Twitter page: "LISTEN: Don’t miss NCI’s exclusive interview on our…
135
136
137
138
139
All:
3119
Posts:
1361 - 1370
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube